MedPath

Pilot Mobile for Dementia and Frailty

Phase 1
Completed
Conditions
Dementia
Frailty
Interventions
Other: Usual Care
Other: Mobile app
Registration Number
NCT05827094
Lead Sponsor
University of Washington
Brief Summary

In this project, we propose to build on our Stage I formative work (according to the NIH Stage Model for Behavioral Intervention Development), where we developed fully functional prototypes of a mobile intervention aimed at improving adherence to Mediterranean Diet (MedD) for older adults with frailty and early dementia to complete the Stage II exploratory work, where the intervention will undergo further feasibility, acceptability, and preliminary efficacy tests. The intervention includes a patient-facing app that allows users to track their diet and receive personalized feedback concerning opportunities for improvement and recipes for breakfast, lunch, dinner, and snacks, informational materials about MedD, and a chat feature. On the other end, a web-based provider interface allows clinicians to review patient progress, suggest meal plans, and send and receive messages. The pilot randomized controlled trial, conducted over three months, will compare usual care to usual care plus mobile intervention to gather preliminary efficacy data concerning a change in adherence to MedD score (primary outcome). Mechanistic and secondary outcomes will include MedD knowledge, constructs from Social Cognitive Theory (self-efficacy, outcome expectation, self-regulation, and social support), platform use, anthropometric, and functional measures. Feasibility will be evaluated in terms of recruitment and retention outcomes. Acceptability will be determined through post-intervention semi-structured interviews and structured survey measures.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
19
Inclusion Criteria
  1. 65 years or older;
  2. ICD-9-CM (ICD-10-CM) codes for mild or major neurocognitive disorders with mild-to-moderate severity due to several possible etiologies. Specifically, a) mild neurocognitive disorder 331.83 (G31.84); major neurocognitive disorder 294.1x (F02.8x) due to Alzheimer disease 331.0 (G30.9); frontotemporal lobar degeneration 331.19 (G31.09); Lewy body disease 331.82 (G31.83);
  3. mild-to-moderate frailty
  4. own a mobile device.
Read More
Exclusion Criteria
  1. Severe sensory impairment that makes it impossible to operate a mobile device or respond to prompts
  2. English reading level below 6th grade
  3. no care partner
  4. optimal diet
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Usual CareUsual CareParticipants randomly allocated to the control group will receive educational materials on healthy eating, as provided on the NIA web page (https://www.nia.nih.gov/health/healthy-eating).
Mobile IntervnetionMobile appParticipants randomized to the intervention arm will receive verbal and written instructions as well as one-on-one demonstration of the app features. Participants will have an option of either receiving the study mobile device or will be able to use their own device with an installed app. Following the training, participants will be asked to use the app at least once a week.
Primary Outcome Measures
NameTimeMethod
Adherence to Mediterranean Diet (aMed) scoreBaseline; 12 weeks

MedD adherence outcomes will be measured using the FFQ and adherence to MedD (aMED) score

Secondary Outcome Measures
NameTimeMethod
Mediterranean Diet Nutrition Knowledge (MDNK) QuestionnaireBaseline; 12 weeks

Items include questions focused on knowledge about foods and nutrients that are important in the MedD.

Social Cognitive TheoryBaseline; 12 weeks

Social-cognitive theory (SCT) mechanistic variables will be measured using the Food Beliefs Survey and modified to focus on MedD

Short Physical Performance BatteryBaseline; 12 weeks

The Short Physical Performance Battery (SPPB) is designed to measure functional status and physical performance. The scale is a composite measure assessing walking speed, standing balance, and sit-to-stand performance. The three tests are summed to give a total score, with a maximum of 12 and a minimum of 0, with a higher score indicating higher function.

Body Mass IndexBaseline; 12 weeks

Weight to the nearest 0.1 kg and height to the nearest 0.1 cm will be measured and used to compute BMI.

Waist Circumference (WC)Baseline; 12 weeks

WC at the natural waist or narrowest part of the torso will also be measured to the nearest 0.1 cm

Trial Locations

Locations (1)

Univeristy of Washington

🇺🇸

Seattle, Washington, United States

© Copyright 2025. All Rights Reserved by MedPath